#APASLMeeting Archives

APASL 2023 | Prof. Ji Dong: Clinical Characteristics of Elderly Drug-Induced Liver Injury Combined with Autoimmune Phenomena

By Mourabit Halima 2024.01.03

Editor's Note: In recent years, with the increase in health awareness, the incidence of drug-induced liver injury (DILI) has been rising. Immune responses can trigger inflammation and necrosis, leading to…

APASL 2023 | Prof. Ning Qin: New Strategies for Targeting Liver Autophagy Abnormalities in Fatty Liver Disease Interventions

By Mourabit Halima 2024.01.03

Editor's Note: In recent years, the global incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) has been continuously rising, becoming the most common cause of chronic liver disease worldwide, with an…

APASL 2023 | Prof. Wu Chao: Metabolic Predictors and Liver Fibrosis Diagnostic Model Construction for Chronic Hepatitis B Combined with NAFLD

By Mourabit Halima 2024.01.03

Editor's Note: Chronic hepatitis B (CHB) is the primary cause of chronic liver disease in China and other Asian countries, as well as a major contributor to liver-related morbidity and…